Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carrie S Oliphant

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Hospital Pharmacy|January 15, 2014
Analysis of antithrombotic therapy after cardioembolic stroke due to atrial fibrillation or flutterEvan J Peterson, Anne B Reaves, Jennifer L Smith, et al.
Journal of Managed Care Pharmacy : JMCP|January 25, 2014
Analysis of gastrointestinal prophylaxis in patients receiving dual antiplatelet therapy with aspirin and clopidogrelKathleen M Morneau, Anne B Reaves, Julie B Martin, et al.
Journal of Pharmacy Practice|December 10, 2013
Dabigatran Use in the Real World: A Multihospital System ExperienceLauren A Kimmons, Rajesh Kabra, McLisa Davis, et al.
Current Vascular Pharmacology|June 3, 2009
Emerging P2Y12 receptor antagonists: role in coronary artery diseaseCarrie S Oliphant, J Bradford Doby, Crystal L Blade, et al.
Thrombosis Research|December 3, 2014
Fever as a risk factor for increased response to vitamin K antagonists: a review of the evidence and potential mechanismsTimothy H Self, Carrie S Oliphant, Anne B Reaves, et al.
World Journal of Cardiology|August 22, 2017
Peripheral interventions and antiplatelet therapy: Role in current practicePahul Singh, Yenal Harper, Carrie S Oliphant, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 27, 2018
The effect of obesity on the rate of heparin-induced thrombocytopeniaJacob L Marler, G Morgan Jones, Brian J Wheeler, et al.
Journal of Critical Care|August 3, 2016
Effects of propofol on vasopressor use in patients with sepsis and severe sepsis: A pilot studyJacob Marler, Kerry Mohrien, Lauren A Kimmons, et al.
The American Journal of the Medical Sciences|March 20, 2016
Effects of Renin-Angiotensin-Aldosterone System Blockade in Patients with End-Stage Renal DiseaseTeresa Slomka, Emily S Lennon, Hina Akbar, et al.
Pharmacotherapy|May 24, 2014
Evaluation of warfarin dose requirements in patients with chronic kidney disease and end-stage renal diseaseSami A Sakaan, Joanna Q Hudson, Carrie S Oliphant, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Hospital Pharmacy|January 15, 2014
Analysis of antithrombotic therapy after cardioembolic stroke due to atrial fibrillation or flutterEvan J Peterson, Anne B Reaves, Jennifer L Smith, et al.
Journal of Managed Care Pharmacy : JMCP|January 25, 2014
Analysis of gastrointestinal prophylaxis in patients receiving dual antiplatelet therapy with aspirin and clopidogrelKathleen M Morneau, Anne B Reaves, Julie B Martin, et al.
Journal of Pharmacy Practice|December 10, 2013
Dabigatran Use in the Real World: A Multihospital System ExperienceLauren A Kimmons, Rajesh Kabra, McLisa Davis, et al.
Current Vascular Pharmacology|June 3, 2009
Emerging P2Y12 receptor antagonists: role in coronary artery diseaseCarrie S Oliphant, J Bradford Doby, Crystal L Blade, et al.
Thrombosis Research|December 3, 2014
Fever as a risk factor for increased response to vitamin K antagonists: a review of the evidence and potential mechanismsTimothy H Self, Carrie S Oliphant, Anne B Reaves, et al.
World Journal of Cardiology|August 22, 2017
Peripheral interventions and antiplatelet therapy: Role in current practicePahul Singh, Yenal Harper, Carrie S Oliphant, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 27, 2018
The effect of obesity on the rate of heparin-induced thrombocytopeniaJacob L Marler, G Morgan Jones, Brian J Wheeler, et al.
Journal of Critical Care|August 3, 2016
Effects of propofol on vasopressor use in patients with sepsis and severe sepsis: A pilot studyJacob Marler, Kerry Mohrien, Lauren A Kimmons, et al.
The American Journal of the Medical Sciences|March 20, 2016
Effects of Renin-Angiotensin-Aldosterone System Blockade in Patients with End-Stage Renal DiseaseTeresa Slomka, Emily S Lennon, Hina Akbar, et al.
Pharmacotherapy|May 24, 2014
Evaluation of warfarin dose requirements in patients with chronic kidney disease and end-stage renal diseaseSami A Sakaan, Joanna Q Hudson, Carrie S Oliphant, et al.
Pageof 4